NCT07569562

Brief Summary

This study evaluates the clinical, organizational, and care impact of the GetReady digital platform as a clinical decision support tool for the follow-up of patients with cerebral aneurysm. The platform integrates clinical, radiological, and patient-reported data, including PROMs and PREMs, and may incorporate home blood pressure monitoring. The study is an interventional implementation study with retrospective and prospective components. No additional medical, diagnostic, or therapeutic intervention is introduced, and all clinical decisions remain under routine clinical practice.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
32mo left

Started May 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 6, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

May 18, 2026

Expected
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

2.6 years

First QC Date

April 22, 2026

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • EQ-5D-5L index score at 12 months

    Health-related quality of life assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). The EQ-5D-5L evaluates mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The outcome will be reported as the EQ-5D-5L index score.

    Baseline and 12 months after enrollment

Secondary Outcomes (9)

  • EQ-5D-5L visual analogue scale score at 12 months

    12 months after enrollment

  • PPE-15 total score at hospital discharge or post-procedure assessment

    30 days after hospital discharge - post diagnostic procedure and post-therapeutic procedure

  • Net Promoter Score reported by patients for the digital platform

    12 months after enrollment

  • Percentage of scheduled PROM and PREM questionnaires completed through the digital platform

    Up to 12 months after enrollment

  • Percentage of participants remaining active on the digital platform at 12 months

    12 months after enrollment

  • +4 more secondary outcomes

Study Arms (1)

GetReady Digital Follow-up

EXPERIMENTAL

Participants with cerebral aneurysm enrolled in a digital follow-up pathway using the GetReady platform in addition to routine clinical care. The platform is used to collect and integrate clinical, radiological, and patient-reported data, including PROMs and PREMs, and may include home blood pressure monitoring when clinically indicated. The study does not introduce any additional medical, diagnostic, or therapeutic intervention, and all clinical decisions remain under routine practice.

Device: GetReady digital platform

Interventions

CE-marked digital platform used to support follow-up of patients with cerebral aneurysm through structured collection and visualization of clinical, radiological, and patient-reported data during routine care.

GetReady Digital Follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of cerebral aneurysm
  • Access to one of the following: compatible mobile phone, computer, or tablet with internet access
  • Sufficient internet connection for use of the digital platform
  • When the patient cannot or does not wish to use the application directly, participation may occur through a designated caregiver or family member, after informed consent

You may not qualify if:

  • Patients treated with surgical clipping
  • Absence of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2026

First Posted

May 6, 2026

Study Start (Estimated)

May 18, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

May 6, 2026

Record last verified: 2026-04